GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Payments of Debt

ANRO (Alto Neuroscience) Payments of Debt : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Payments of Debt?

Alto Neuroscience's Payments of Debt for the three months ended in Sep. 2024 was $0.00 Mil.

Alto Neuroscience's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Alto Neuroscience Payments of Debt Historical Data

The historical data trend for Alto Neuroscience's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Payments of Debt Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Payments of Debt
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alto Neuroscience Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Payments of Debt Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Payments of Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
369 South San Antonio Road, Los Altos, CA, USA, 94022
Website
https://www.altoneuroscience.com
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.